AM
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
178.82
Exchange
XNAS - Nasdaq
2.5 B
Last period CFO ,USD
74%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Amgen
Company Analysis
AMGN valuation, rating, competitors, insights and company profile
Eyestock Rating
AMGN financial analysis by Eyestock methodology
Valuation
AMGN valuation using historical relative method
Statements
AMGN Income Statements, Balance Sheet and Cash Flow Statements
Dividends
AMGN dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Amgen`s CFO for the period ended 2024-06-30 is 2.5 B USD
